recent articles
Roche awarded WHO prequalification for the cobas® HPV test, increasing access to cervical cancer screening tools in low and lower-middle income countries Every year, over 600,000 women worldwide are diagnosed with cervical cancer and over...
Media Release: Roche receives FDA approval for cobas HPV test for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancer More than 99 percent of cervical cancers are caused by persistent high-risk HPV...
Courtesy of colLABoration: A Sharing of Insights for Enhancing Laboratories and Laboratory Informatics Advisory Panel Recommends HPV as First-line Screen An advisory panel for the Medical Devices Committee of the FDA voted unanimously to...
© 2023 Tissuepathology.com. All rights reserved. Millennial Consulting. | Web Design by Zealth Digital Marketing